SETD2 regulates the methylation of translation elongation factor eEF1A1 in clear cell renal cell carcinoma

SET domain-containing protein 2 (SETD2) is commonly mutated in renal cell carcinoma. SETD2 methylates histone H3 as well as a growing list of non-histone proteins. To explore SETD2-dependent regulation of the kidney cancer proteome, we performed a systems-wide analysis of protein lysine-methylation and expression in wild type (WT) and SETD2-knock out (KO) kidney cells. We observed decreased lysine methylation of the translation elongation factor eEF1A1. EEF1AKMT2 and EEF1AKMT3 are known to methylate eEF1A1, and we show here that their expression is dependent on SET-domain function of SETD2. Globally, we observe differential expression of hundreds of proteins in WT versus SETD2-KO cells, including increased expression of many involved in protein translation. Finally, we observe decreased progression free survival and loss of EEF1AKMT2 gene expression in SETD2-mutated tumors. Overall, these data suggest that SETD2-mutated ccRCC, via loss of enzymetic function of the SET domain, displays dysregulation of protein translation as a potentially important component of the transformed phenotype.

[1]  Jian Zhang,et al.  SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways. , 2020, Cancer cell.

[2]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[3]  Joshua E. Elias,et al.  METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis , 2019, Cell.

[4]  Sebastian A. Leidel,et al.  The dual methyltransferase METTL13 targets N terminus and Lys55 of eEF1A and modulates codon-specific translation rates , 2018, Nature Communications.

[5]  J. Parker,et al.  SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma. , 2018, Cancer research.

[6]  J. Frank,et al.  New Insights into Ribosome Structure and Function. , 2018, Cold Spring Harbor perspectives in biology.

[7]  P. A. Futreal,et al.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.

[8]  M. Wilkins,et al.  Methylation of Elongation Factor 1A: Where, Who, and Why? , 2018, Trends in biochemical sciences.

[9]  Dan Han,et al.  Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity , 2017, Cell.

[10]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[11]  M. Wilkins,et al.  METTL21B Is a Novel Human Lysine Methyltransferase of Translation Elongation Factor 1A: Discovery by CRISPR/Cas9 Knockout* , 2017, Molecular & Cellular Proteomics.

[12]  Sebastian A. Leidel,et al.  Methylation of human eukaryotic elongation factor alpha (eEF1A) by a member of a novel protein lysine methyltransferase family modulates mRNA translation , 2017, Nucleic acids research.

[13]  Jing Wang,et al.  WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit , 2017, Nucleic Acids Res..

[14]  Giulia Basile,et al.  Intragenic DNA methylation prevents spurious transcription initiation , 2017, Nature.

[15]  Sebastian A. Leidel,et al.  The novel lysine specific methyltransferase METTL21B affects mRNA translation through inducible and dynamic methylation of Lys-165 in human eukaryotic elongation factor 1 alpha (eEF1A) , 2017, Nucleic acids research.

[16]  W. Rathmell,et al.  Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making? , 2017, Cancer.

[17]  Andy H. Vo,et al.  Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation* , 2016, The Journal of Biological Chemistry.

[18]  T. Ho,et al.  Dual Chromatin and Cytoskeletal Remodeling by SETD2 , 2016, Cell.

[19]  J. Pow-Sang,et al.  Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry–Based Phosphotyrosine Proteomics , 2016, Clinical Cancer Research.

[20]  Gerben Duns,et al.  SETD2: an epigenetic modifier with tumor suppressor functionality , 2016, Oncotarget.

[21]  Zhe Zhang,et al.  METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion , 2016, Scientific Reports.

[22]  Karl J. Dykema,et al.  High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma , 2015, Oncogene.

[23]  S. Saha,et al.  Monitoring newly synthesized proteins over the adult life span of Caenorhabditis elegans. , 2015, Journal of proteome research.

[24]  Allison Doerr.  DIA mass spectrometry , 2014, Nature Methods.

[25]  S. Li,et al.  Non-histone protein methylation as a regulator of cellular signalling and function , 2014, Nature Reviews Molecular Cell Biology.

[26]  Mohammad Al Hasan,et al.  Pathway and network analysis in proteomics. , 2014, Journal of theoretical biology.

[27]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[28]  Daniel B. McClatchy,et al.  PSEA-Quant: A Protein Set Enrichment Analysis on Label-Free and Label-Based Protein Quantification Data , 2014, Journal of proteome research.

[29]  Y. Shinkai,et al.  Selenium-Based S-Adenosylmethionine Analog Reveals the Mammalian Seven-Beta-Strand Methyltransferase METTL10 to Be an EF1A1 Lysine Methyltransferase , 2014, PloS one.

[30]  Yan Guo,et al.  Advanced Heat Map and Clustering Analysis Using Heatmap3 , 2014, BioMed research international.

[31]  J. Desterro,et al.  SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint , 2014, eLife.

[32]  Joel S Parker,et al.  Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects , 2014, Genome research.

[33]  P. D. Nagy,et al.  Methylation of translation elongation factor 1A by the METTL10-like See1 methyltransferase facilitates tombusvirus replication in yeast and plants. , 2014, Virology.

[34]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[35]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[36]  D. Harrich,et al.  The Unexpected Roles of Eukaryotic Translation Elongation Factors in RNA Virus Replication and Pathogenesis , 2013, Microbiology and Molecular Reviews.

[37]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[38]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[39]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[40]  F. Waldman,et al.  Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors , 2008, Clinical Cancer Research.

[41]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[42]  L. Mahadevan,et al.  Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation , 2007, The EMBO journal.

[43]  F. Sherman,et al.  Methylation of proteins involved in translation , 2007, Molecular microbiology.

[44]  M. Mann,et al.  A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.

[45]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Gnarra,et al.  Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. , 2003, Cancer cell.

[47]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[48]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[49]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[50]  J. Rhim,et al.  Cell lines with extended in vitro growth potential from human renal proximal tubule: characterization, response to inducers, and comparison with established cell lines. , 1997, The Journal of laboratory and clinical medicine.

[51]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[52]  M. Mann,et al.  Stable isotope labeling by amino acids in cell culture for quantitative proteomics. , 2007, Methods in molecular biology.